Cognate BioServices is a contract development and manufacturing company that specializes in cell and cell-mediated gene therapies and products with expertise in immunotherapy and regenerative medicine. In addition, the company provides PAI inspection for personalized and off-the-shelf cellular immunotherapy products including CAR-T, TCR, TIL, MIL, DC, and NK cells. Cognate BioServices merged with Charles River Laboratories to form Charles River Laboratories.